Resolution of the Expert Council «Unexplored Dyspepsia: Short-term and Long-term Patient Management Strategies»

Purpose. To present the materials of Expert Council, which was held on April 22, 2023 in Moscow and dedicated to modern approaches management patients with unexplored dyspepsia, as well choice optimal Helicobacter pylori eradication therapy scheme Russian Federation. The main provisions resolution. An initial patient recent dyspeptic symptoms who has not taken drugs that can cause gastric damage should be considered a undiagnosed dyspepsia. first diagnosis excluded dyspepsia is H. pylori-associated chronic gastritis. In order alleviate or eliminate period before testing for pylori, appointment prokinetic itopride hydrochloride recommended, given lack influence results examination, proven efficacy high safety profile, demonstrated studies original drug. patient's presence objective signs gastrointestinal bleeding, unmotivated weight loss, aggravated family history cancer, age over 50 years are indications esophagogastroduodenoscopy biopsy. positive test an indication therapy, infection major etiological factor adenocarcinoma, including proximal cancer gastroesophageal junction. Quadruple clarithromycin (amoxicillin + proton pump inhibitor bismuth tripotassium dicitrate) 14 days defined first-line increase effectiveness eradication, use preparations recommended